Abstract
Aims: To compare the long-term prognosis of younger and elderly patients with combined hepatocellular-cholangiocarcinoma (CHC) who underwent curative resection between 1993 and 2014 at our center. Methods: Two hundred and thirteen patients who underwent liver resection for CHC were enrolled in our study. The overall survival (OS) and disease-free survival (DFS) of elderly patients (age≥60, n=52) and younger patients (age < 60, n=161) were compared by multivariate analysis and propensity score matching (PSM) analysis. Results: Among the 213 CHC patients, the elderly patients had a higher rate of worse Child-Pugh grade (P=0.027), abnormal serum albumin (P < 0.001) and lymphoid metastases (P=0.024). The proportion of HBV-positive CHC patients (74.6%, 159/213) 74.6%, 159/213) 74.6%, 159/213) 74.6%, 159/213) 74.6%, 159/213) 74.6%, 159/213) 74.6%, 159/213) 74.6%, 159/213) 74.6%, 159/213) 74.6%, 159/213) 74.6%, 159/213) 74.6%, 159/213) 74.6%, 159/213) was much higher than that observed in healthy cohorts. Younger patients had a higher rate of hepatitis B virus (HBV) infection compared to older patients (83.9% vs 46.2%, P < 0.001). OS and DFS of the elderly and younger patients before and after propensity score matching were comparable. Conclusion: Elderly and younger patients who underwent liver resection for CHC have comparable long-term OS and DFS.
Author supplied keywords
Cite
CITATION STYLE
Tao, C. Y., Liu, W. R., Jin, L., Tang, Z., Tian, M. X., Jiang, X. F., … Shi, Y. H. (2018). Surgical treatment of combined hepatocellular-cholangiocarcinoma is as effective in elderly patients as it is in younger patients: A propensity score matching analysis. Journal of Cancer, 9(6), 1106–1112. https://doi.org/10.7150/jca.23921
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.